NL-OMON23278尚未招募不适用
Efficacy and safety of first-line therapy with chlorambucil, rituximab and lenalidomide (Revlimid®) (CR2) in elderly patients and young frail patients with advanced Chronic Lymphocytic Leukemia (CLL): A phase II trial.
Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedP.O. box 52013008 AE RotterdamTel: +31 10 7041560Fax: +31 10 7041028e-mail: hdc@erasmusmc.nl0 个研究点目标入组 62 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 62
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Diagnosis of CLL without prior treatment;
- •2. Patients with symptomatic (according to IWCLL guidelines) stage A or stage B or stage C;
排除标准
- •1. Patients that are unable or unwilling to adhere to the requirements of the Lenalidomide Pregnancy Prevention Risk Management Plan;
- •2. Intolerance of exogenous protein administration;
研究者
相似试验
已完成
2 期
Efficacy and safety of first-line therapy with chlorambucil, rituximab and lenalidomide (Revlimid®) (CR2) in elderly patients and young frail patients with advanced Chronic Lymphocytic Leukemia (CLL): a phase II trialChronic Lymphatic Leukemia10024324CLLNL-OMON36713HOVO62
招募中
不适用
A trial to investigate the efficacy and feasibility of treatment with dose adjusted EPOCH-R (DA-EPOCH-R), adapted to risk profile in patients with newly diagnosed Burkitt lymphoma.NL-OMON26111VU University Medical Center Amsterdam22
尚未招募
不适用
The safety and efficacy of Korean medicine including Rhus vernificlua stokes combined with 1st line chemotherapy for advanced or metastatic pancreatic cancer patientsKCT0007496Kyung Hee University30
招募中
不适用
Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma PatientsCancer Of PancreasNCT06046794Institut Paoli-Calmettes100
Unknown
不适用
Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLCEffect IncreasedSafety IssuesNCT04360655Shanghai Pulmonary Hospital, Shanghai, China50